Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.

Cohen J; Division of Human Subject Protection, Office for Human Research Protection, Rockville, Md..

AIDS Read. 2001 Jan;11(1):41-2.

PMID:
11215087
2.

HIV clinical trials in correctional settings: right or retrogression?

De Groot AS, Bick J, Thomas D, Stubblefield E.

AIDS Read. 2001 Jan;11(1):34-40. Review.

PMID:
11215086
3.

Prisoners' access to HIV experimental trials: legal, ethical, and practical considerations.

Potler C, Sharp VL, Remick S.

J Acquir Immune Defic Syndr. 1994 Oct;7(10):1086-94. Review.

PMID:
8083827
4.

Confining choices: should inmates' participation in research be limited?

Pasquerella L.

Theor Med Bioeth. 2002;23(6):519-36. Review.

PMID:
12546168
5.

Protection of research subjects with emphasis on protocols involving radiation.

Classic KL, Porter BL, DiMagno EP.

Health Phys. 2001 May;80(5 Suppl):S70-6. Review.

PMID:
11316087
6.

The impact of escalating regulatory requirements on the conduct of clinical research.

Gordon BG, Kessinger A, Mann SL, Prentice ED.

Cytotherapy. 2003;5(4):309-13. Review.

PMID:
12944237
7.

Human immunodeficiency virus in correctional facilities: a review.

Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP.

Clin Infect Dis. 2002 Aug 1;35(3):305-12. Epub 2002 Jul 3. Review.

PMID:
12115097
8.

Working with the institutional review board.

Byerly WG.

Am J Health Syst Pharm. 2009 Jan 15;66(2):176-84. doi: 10.2146/ajhp070066. Review.

PMID:
19139484
9.

Navigating federalwide assurance requirements when conducting research in community-based care settings.

Cartwright JC, Hickman SE, Bevan L, Shupert CL.

J Am Geriatr Soc. 2004 Sep;52(9):1567-71. Review.

PMID:
15341563
10.

The impact of AIDS on drug availability and accessibility.

Gilmore N.

AIDS. 1991;5 Suppl 2:S253-62. Review. No abstract available.

PMID:
1845055
11.

Issues in the design of clinical trials for safety in HIV-infected children.

Lindsey JC, Kline MW.

Pediatr AIDS HIV Infect. 1996 Apr;7(2):69-82. Review.

PMID:
11361484
12.

Challenges to conducting HIV preventative vaccine trials with adolescents.

McClure CA, Gray G, Rybczyk GK, Wright PF.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):726-33. Review.

PMID:
15167292
13.
14.

Drug approval and AIDS: benefits for the elderly.

Rothman DJ, Edgar H.

Health Aff (Millwood). 1990 Fall;9(3):123-30. Review. No abstract available.

15.

How are drugs approved? Part 2: ethical foundations of clinical research.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Feb;46(2):15-20. Review.

PMID:
18293779
16.

A review of the legal and ethical issues for the conduct of HIV-related research in prisons.

Lazzarini Z, Altice FL.

AIDS Public Policy J. 2000 Fall-Winter;15(3-4):105-35. Review.

PMID:
12189712
17.

Ethical Considerations for Research Involving Prisoners.

Institute of Medicine (US) Committee on Ethical Considerations for Revisions to DHHS Regulations for Protection of Prisoners Involved in Research; Gostin LO, Vanchieri C, Pope A, editors.

Washington (DC): National Academies Press (US); 2007.

18.

Realizing the promise of the US Food and Drug Administration Modernization Act.

Wolgemuth RL.

Clin Ther. 1998;20 Suppl C:C26-31. Review.

PMID:
9915087
19.

Trials and tribulations: ethical dilemmas in HIV therapy.

Weber J.

Curr Opin Immunol. 1997 Oct;9(5):625-7. Review. No abstract available.

PMID:
9368768
20.

Antioxidant therapy for AIDS.

Staal F.

Eur J Clin Invest. 2000 Oct;30(10):841-2. Review. No abstract available.

PMID:
11029596

Supplemental Content

Support Center